Inhibrx Biosciences, Inc. INBX Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s common stock?
- Inhibrx Biosciences, Inc. (INBX) reported common stock of 120M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s common stock changed year-over-year?
- Inhibrx Biosciences, Inc.'s common stock decreased by 0.0% year-over-year, from 120M to 120M.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s common stock?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s common stock has grown at a 15391.9% compound annual growth rate (CAGR), from 5K to 120M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).